Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
BSE · INR · Healthcare · Biotechnology
₹9.15 (+0.66%) as of
Key statistics
- Market cap
- 395.10M
- EPS (TTM)
- -2.47
- Dividend yield
- 0.00%
- 52-week range
- 7.11 – 22.61
- Beta
- 0.47
- Revenue (TTM)
- 76.5M
- Profit margin
- -241.59%
- Volume
- 5.85k
About Bharat Immunologicals & Biologicals Corporation Limited
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Bulandshahr, India
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.